Vaccine Adjuvants Market Size by Application, Type, Regional, Industry
Statistics & Forecast 2021 – 2025
Global Vaccine Adjuvants market Size by Type, End User and Application: Global Opportunity
Analysis and Industry Forecast, 2020-2025. The base year considered for the study is 2020, and the
forecast has been provided for the period from 2020 to 2025.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce
protection against infection. Adjuvants are substances added to vaccines to enhance the
immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities,
and have been used in human vaccines for more than 90 years. And many vaccines also contain an
adjuvant or adjuvant combination: these are substances added to vaccines specifically because of
their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic
potential of highly purified antigens. In recent years their role has expanded as our understanding
of the immunology of vaccination has grown.
The classification of vaccine adjuvants includes veterinary vaccine adjuvants and human vaccine
adjuvants. And the proportion of human vaccine adjuvants in 2019 is about 52.4%. The veterinary
vaccine adjuvants in 2015 are about 47.6%.
The classification of Veterinary Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and
Others. And the proportion of Intramuscular in 2019 is about 56.3%. The Subcutaneous in 2019 is
The classification of Human Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and
Others. And the proportion of Intramuscular in 2019 is about 55.5%. The Subcutaneous in 2019 is
According to this study Vaccine Adjuvants market will register a 10.3% CAGR in terms of revenue,
the global market size will reach US$ 1010 million by 2025, from US$ 560 million in 2020.
The research report offers an outlook of the attractiveness of the segments and regions, which are